Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: Involvement of pertussis toxin-sensitive G-protein coupled receptor

FEBS Letters

Volumn 581, Issue 23, 2007, Pages 4411-4416

  Park, Kyoung Sun ^a   Lee, Ha Young ^a   Lee, Sun Young ^a   Kim, Mi Kyoung ^a   Kim, Sang Doo ^a   Kim, Jung Mo ^a   Yun, Jeanho ^a   Im, Dong Soon ^b   Bae, Yoe Sik ^a  

^a Dong A University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Chemotactic migration; G protein coupled receptor; Invasion; Lysophosphatidylethanolamine; Ovarian cancer cell; Pertussis toxin sensitive G protein

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; LYSOPHOSPHATIDYLCHOLINE; PERTUSSIS TOXIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL STRAIN HEPG2; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

CALCIUM; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; LUCIFERASES; LYSOPHOSPHOLIPIDS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PERTUSSIS TOXIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TYPE C PHOSPHOLIPASES; U937 CELLS;

EID: 34548442406     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.08.014     Document Type: Article

References (25)

1. Graler M.H., and Goetzl E.J. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta 1582 (2002) 168-174
2. Steiner M.R., Urso J.R., Klein J., and Steiner S.M. Multiple astrocyte responses to lysophosphatidic acids. Biochim. Biophys. Acta 1582 (2002) 154-160
3. Fang X., Schummer M., Mao M., Yu S., Tabassam F.H., Swaby R., Hasegawa Y., Tanyi J.L., LaPushin R., Eder A., Jaffe R., Erickson J., and Mills G.B. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta 1582 (2002) 257-264
4. Xie Y., Gibbs T.C., Mukhin Y.V., and Meier K.E. Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J. Biol. Chem. 277 (2002) 32516-32526
5. Kim J.I., Jo E.J., Lee H.Y., Kang H.K., Lee Y.N., Kwak J.Y., and Bae Y.S. Stimulation of early gene induction and cell proliferation by lysophosphatidic acid in human amnion-derived WISH cells: role of phospholipase D-mediated pathway. Biochem. Pharmacol. 68 (2004) 333-340
6. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., Ohta H., Yamori T., Watanabe M., Chun J., and Arai H. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 279 (2004) 17634-17639
7. Ren J., Xiao Y.J., Singh L.S., Zhao X., Zhao Z., Feng L., Rose T.M., Prestwich G.D., and Xu Y. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. 66 (2006) 3006-3014
8. Budnik L.T., and Mukhopadhyay A.K. Lysophosphatidic acid antagonizes the morphoregulatory effects of the luteinizing hormone on luteal cells: possible role of small Rho-G-proteins. Biol. Reprod. 65 (2001) 180-187
9. Daaka Y. Mitogenic action of LPA in prostate. Biochim. Biophys. Acta 1582 (2002) 265-269
10. Park K.S., Lee H.Y., Kim M.K., Shin E.H., and Bae Y.S. Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes. Biochem. Biophys. Res. Commun. 333 (2005) 353-358
11. Park K.S., Lee H.Y., Kim M.K., Shin E.H., Jo S.H., Kim S.D., Im D.S., and Bae Y.S. Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins. Mol. Pharmacol. 69 (2006) 1066-1073
12. Park K.S., Kim M.K., Im D.S., and Bae Y.S. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. Biochem. Pharmacol. 73 (2007) 675-681
13. Nishina A., Kimura H., Sekiguchi A., Fukumoto R.H., Nakajima S., and Furukawa S. Lysophosphatidylethanolamine in Grifola frondosa as a neurotrophic activator via activation of MAPK. J. Lipid Res. 47 (2006) 1434-1443
14. Caccin P., Rigoni M., Bisceglie A., Rossetto O., and Montecucco C. Reversible skeletal neuromuscular paralysis induced by different lysophospholipids. FEBS Lett. 580 (2006) 6317-6321
15. Bae Y.S., Bae H., Kim Y., Lee T.G., Suh P.G., and Ryu S.H. Identification of novel chemoattractant peptides for human leukocytes. Blood 97 (2001) 2854-2862
16. Lee H.Y., Park K.S., Kim M.K., Lee T., Ryu S.H., Woo K.J., Kwon T.K., and Bae Y.S. A small compound that inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 upregulation. Biochem. Biophys. Res. Commun. 336 (2005) 716-722
17. Noh D.Y., Shin S.H., and Rhee S.G. Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim. Biophys. Acta 1242 (1995) 99-113
18. Lee S., and Lynch K.R. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA). Biochem. J. 391 (2005) 317-323
19. Ohta H., Sato K., Murata N., Damirin A., Malchinkhuu E., Kon J., Kimura T., Tobo M., Yamazaki Y., Watanabe T., Yagi M., Sato M., Suzuki R., Murooka H., Sakai T., Nishitoba T., Im D.S., Nochi H., Tamoto K., Tomura H., and Okajima F. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 64 (2003) 994-1005
20. Xu Y., Fang X.J., Casey G., and Mills G.B. Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309 (1995) 933-940
21. Xu Y., Gaudette D.C., Boynton J.D., Frankel A., Fang X.J., Sharma A., Hurteau J., Casey G., Goodbody A., Mellors A., Holub B.J., and Mills G.B. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1 (1995) 1223-1232
22. Mills G.B., Eder A., Fang X., Hasegawa Y., Mao M., Lu Y., Tanyi J., Tabassam F.H., Wiener J., Lapushin R., Yu S., Parrott J.A., Compton T., Tribley W., Fishman D., Stack M.S., Gaudette D., Jaffe R., Furui T., Aoki J., and Erickson J.R. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treat Res. 107 (2002) 259-283
23. Symowicz J., Adley B.P., Woo M.M., Auersperg N., Hudson L.G., and Stack M.S. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res. 65 (2005) 2234-2242
24. Hu Y.L., Tee M.K., Goetzl E.J., Auersperg N., Mills G.B., Ferrara N., and Jaffe R.B. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J. Natl.Cancer Inst. 93 (2001) 762-768
25. Pustilnik T.B., Estrella V., Wiener J.R., Mao M., Eder A., Watt M.A., Bast Jr. R.C., and Mills G.B. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin. Cancer Res. 5 (1999) 3704-3710